Results 151 to 160 of about 1,590 (205)
Cancer Science, Volume 117, Issue 6, Page 1690-1700, June 2026.Daunorubicin dose escalation from 45 to 60 mg/m2 provides no clinical benefit for AML patients aged 55–65. A dose of 45 mg/m2 should remain the preferred regimen for this population. ABSTRACT Daunorubicin dose optimization remains crucial for AML treatment.
Chunlin Zhou +15 more
wiley +1 more source
International Journal of Laboratory Hematology, Volume 48, Issue 3, Page 521-530, June 2026.ABSTRACT Hematologic emergencies are urgent health conditions which result in significant mortality and morbidity unless timely therapeutic measures are taken. Therapeutic success depends on their timely and accurate recognition by hematology laboratory services.
Ganna Shestakova +2 more
wiley +1 more source
Benefit of immune checkpoint inhibitors as adjuvant treatment for acral melanomas
Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 6, Page 1069-1077, June 2026.When questioning the effectiveness of adjuvant immunotherapy for acral melanomas, we found no clinical benefit to the adjuvant proposal, despite the maintenance of adverse effects. Abstract Background Solar factors play no role in the development of acral melanoma (AM). AM is characterized by low cumulative solar damage (low CSD).
Damien Sanogo +13 more
wiley +1 more source
The One Lonely Little Guy Versus Thousand Lobbyists: George H. W. Bush and the American Jews
Presidential Studies Quarterly, Volume 56, Issue 2, June 2026.ABSTRACT This article reconsiders the strained relationship between President George H. W. Bush and the American Jewish community during the early 1990s, focusing on the controversy surrounding Israel's request for US loan guarantees and Bush's September 1991 “lonely little guy” remark.
David Tal
wiley +1 more source
Veterinary and Comparative Oncology, Volume 24, Issue 2, Page 324-340, June 2026.ABSTRACT Pet dogs with naturally occurring cancers provide valuable models for comparative oncology and pathology tumour registries offer a powerful resource for onco‐epidemiological research. Here, we analysed the Small Animal Veterinary Surveillance Network (SAVSNET) pathology‐based tumour registry (PTR), one of the largest veterinary tumour ...
José Rodríguez +9 more
wiley +1 more source
Redox Disruption Induced by Saquayamycin B1 Promotes Cytotoxicity in Resistant Melanoma Cells
ChemMedChem, Volume 21, Issue 10, 27 May 2026.Saquayamycin B1 (SQ‐B1), an antibiotic isolated from Streptomyces sp. I072, triggers cell death in different melanoma cell lines, including chemoresistant SK‐MEL‐5. SQ‐B1 elevates O2•‐ and NO• on both sides of the membrane and blocks glutathione transferase (GSTP‐1) and glutathione reductase (GSR), destabilizing the GSH/GSSG antioxidant system.
Geovana Guedes Silvestre +13 more
wiley +1 more source
Adjuvant treatment for acral melanoma
Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 6, Page 934-935, June 2026.
Takaya Komori, Yasuhiro Nakamura
wiley +1 more source
Plenary Abstracts Session & Oral Presentations
HemaSphere, Volume 10, Issue S1, June 2026.
wiley +1 more source